XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Risk Management and Derivatives (Tables) | 9 Months Ended
--- | ---
Feb. 28, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of February 28, 2017 and May 31, 2016, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
|  | As of February 28, 2017
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Assets at Fair Value |  | Other Current Assets |  | Other Long-term Assets |  | Liabilities at Fair Value |  | Accrued Liabilities |  | Other Long-term Liabilities
Level 2: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options(1) |  | $ | 607 |  |  | $ | 493 |  |  | $ | 114 |  |  | $ | 116 |  |  | $ | 114 |  |  | $ | 2 |
Embedded derivatives |  | 9 |  |  | 1 |  |  | 8 |  |  | 10 |  |  | 4 |  |  | 6 |
TOTAL |  | $ | 616 |  |  | $ | 494 |  |  | $ | 122 |  |  | $ | 126 |  |  | $ | 118 |  |  | $ | 8 |
(1) | If the foreign exchange derivative instruments had been netted on the Unaudited Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $114 million as of February 28, 2017. As of that date, the Company had received $293 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company's derivative liability balance as of February 28, 2017.
|  | As of May 31, 2016
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Assets at Fair Value |  | Other Current Assets |  | Other Long-term Assets |  | Liabilities at Fair Value |  | Accrued Liabilities |  | Other Long-term Liabilities
Level 2: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options(1) |  | $ | 603 |  |  | $ | 487 |  |  | $ | 116 |  |  | $ | 145 |  |  | $ | 115 |  |  | $ | 30 |
Embedded derivatives |  | 7 |  |  | 2 |  |  | 5 |  |  | 9 |  |  | 2 |  |  | 7 |
Interest rate swaps(2) |  | 7 |  |  | 7 |  |  | — |  |  | 45 |  |  | 45 |  |  | — |
TOTAL |  | $ | 617 |  |  | $ | 496 |  |  | $ | 121 |  |  | $ | 199 |  |  | $ | 162 |  |  | $ | 37 |
(1) | If the foreign exchange derivative instruments had been netted on the Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $136 million as of May 31, 2016. As of that date, the Company had received $105 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2016.
(2) | As of May 31, 2016, no amount of cash collateral had been received or posted on the derivative asset or liability balance related to the Company's interest rate swaps.
The following table presents the fair values of derivative instruments included within the Unaudited Condensed Consolidated Balance Sheets as of February 28, 2017 and May 31, 2016:
|  | Derivative Assets |  | Derivative Liabilities
(In millions) |  | Balance Sheet Location |  | February 28, 2017 |  | May 31, 2016 |  | Balance Sheet Location |  | February 28, 2017 |  | May 31, 2016
Derivatives formally designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options |  | Prepaid expenses and other current assets |  | $ | 366 |  |  | $ | 447 |  |  | Accrued liabilities |  | $ | 35 |  |  | $ | 38 |
Interest rate swaps |  | Prepaid expenses and other current assets |  | — |  |  | 7 |  |  | Accrued liabilities |  | — |  |  | 45 |
Foreign exchange forwards and options |  | Deferred income taxes and other assets |  | 100 |  |  | 90 |  |  | Deferred income taxes and other liabilities |  | 2 |  |  | 12 |
Total derivatives formally designated as hedging instruments |  |  |  | 466 |  |  | 544 |  |  |  |  | 37 |  |  | 95 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options |  | Prepaid expenses and other current assets |  | 127 |  |  | 40 |  |  | Accrued liabilities |  | 79 |  |  | 76 |
Embedded derivatives |  | Prepaid expenses and other current assets |  | 1 |  |  | 2 |  |  | Accrued liabilities |  | 4 |  |  | 2 |
Foreign exchange forwards and options |  | Deferred income taxes and other assets |  | 14 |  |  | 26 |  |  | Deferred income taxes and other liabilities |  | — |  |  | 19 |
Embedded derivatives |  | Deferred income taxes and other assets |  | 8 |  |  | 5 |  |  | Deferred income taxes and other liabilities |  | 6 |  |  | 7 |
Total derivatives not designated as hedging instruments |  |  |  | 150 |  |  | 73 |  |  |  |  | 89 |  |  | 104 |
TOTAL DERIVATIVES |  |  |  | $ | 616 |  |  | $ | 617 |  |  |  |  | $ | 126 |  |  | $ | 199 |
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following tables present the amounts affecting the Unaudited Condensed Consolidated Statements of Income for the three and nine months ended February 28, 2017 and February 29, 2016:
(In millions) | Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivatives(1) |  | Amount of Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income(1)
Three Months Ended |  | Location of Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income |  | Three Months Ended
February 28, 2017 |  | February 29, 2016 |  |  | February 28, 2017 |  | February 29, 2016
Derivatives designated as cash flow hedges: |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options | $ | 5 |  |  | $ | 107 |  |  | Revenues |  | $ | 24 |  |  | $ | (24 | )
Foreign exchange forwards and options | (5 | ) |  | (142 | ) |  | Cost of sales |  | 87 |  |  | 153 |
Foreign exchange forwards and options | (3 | ) |  | — |  |  | Total selling and administrative expense |  | — |  |  | — |
Foreign exchange forwards and options | 4 |  |  | (91 | ) |  | Other (income) expense, net |  | 67 |  |  | 73 |
Interest rate swaps | — |  |  | (49 | ) |  | Interest expense (income), net |  | (2 | ) |  | — |
Total designated cash flow hedges | $ | 1 |  |  | $ | (175 | ) |  |  |  | $ | 176 |  |  | $ | 202 |
(1) | For the three months ended February 28, 2017 and February 29, 2016, the amounts recorded in Other (income) expense, net as a result of hedge ineffectiveness and the discontinuance of cash flow hedges because the forecasted transactions were no longer probable of occurring were immaterial.
(In millions) | Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivatives(1) |  | Amount of Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income(1)
Nine Months Ended |  | Location of Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income |  | Nine Months Ended
February 28, 2017 |  | February 29, 2016 |  |  | February 28, 2017 |  | February 29, 2016
Derivatives designated as cash flow hedges: |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options | $ | 45 |  |  | $ | 97 |  |  | Revenues |  | $ | 96 |  |  | $ | (99 | )
Foreign exchange forwards and options | 244 |  |  | 63 |  |  | Cost of sales |  | 260 |  |  | 451 |
Foreign exchange forwards and options | (1 | ) |  | — |  |  | Total selling and administrative expense |  | — |  |  | — |
Foreign exchange forwards and options | 149 |  |  | 31 |  |  | Other (income) expense, net |  | 141 |  |  | 173 |
Interest rate swaps | (54 | ) |  | (99 | ) |  | Interest expense (income), net |  | (2 | ) |  | — |
Total designated cash flow hedges | $ | 383 |  |  | $ | 92 |  |  |  |  | $ | 495 |  |  | $ | 525 |
(1) | For the nine months ended February 28, 2017 and February 29, 2016, the amounts recorded in Other (income) expense, net as a result of hedge ineffectiveness and the discontinuance of cash flow hedges because the forecasted transactions were no longer probable of occurring were immaterial.
|  | Amount of Gain (Loss) Recognized in Income on Derivatives |  | Location of Gain (Loss) Recognized in Income on Derivatives
|  | Three Months Ended |  | Nine Months Ended |
(In millions) |  | February 28, 2017 |  | February 29, 2016 |  | February 28, 2017 |  | February 29, 2016 |
Derivatives designated as fair value hedges: |  |  |  |  |  |  |  |  |  |
Interest rate swaps(1) |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 2 |  |  | Interest expense (income), net
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Foreign exchange forwards and options |  | (66 | ) |  | (30 | ) |  | 101 |  |  | 4 |  |  | Other (income) expense, net
Embedded derivatives |  | (1 | ) |  | (3 | ) |  | (2 | ) |  | (3 | ) |  | Other (income) expense, net
(1) | All interest rate swaps designated as fair value hedges meet the shortcut method requirements under U.S. GAAP. Accordingly, changes in the fair values of the interest rate swaps are considered to exactly offset changes in the fair value of the underlying long-term debt. Refer to “Fair Value Hedges” in this note for additional detail.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration